Symons Julian A.
Insider CIK 1824727 · ALGS See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2026-03-09 | 2026-03-11 | 23,310 | — | $0 | 23,310 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2025-07-16 | 2025-07-18 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2025-02-28 | 2025-03-04 | 21,693 | — | $0 | 21,693 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-09-04 | 2024-09-06 | 10,880 | — | $0 | 10,880 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 72,000 | — | $0 | 72,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 74,998 | — | $0 | 74,998 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 58,822 | — | $0 | 58,822 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 26,250 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 200,000 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 105,000 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-09-08 | 2023-09-12 | 48,000 | — | $0 | 48,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-03-15 | 2023-03-17 | 78,750 | — | $0 | 78,750 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-07-07 | 2022-07-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 26,250 | — | $0 | 26,250 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 105,000 | — | $0 | 105,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2020-12-01 | 2020-12-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 13,671 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 3,394 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 1,452 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 1,452 | — | $0 | 394,064 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 3,394 | — | $0 | 392,612 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 13,671 | — | $0 | 389,218 | SEC↗ |